Cargando…

Ingestion of low-dose ibuprofen following resistance exercise in postmenopausal women

BACKGROUND: Postmenopausal women typically experience accelerated muscle loss which has a negative effect on strength. The maximum daily recommended dosage of ibuprofen (1,200 mg) following resistance exercise has been shown to increase muscle hypertrophy and strength in older adults. This study aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Candow, Darren G., Chilibeck, Philip D., Weisgarber, Krissy, Vogt, Emelie, Baxter-Jones, Adam D. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581617/
https://www.ncbi.nlm.nih.gov/pubmed/22777756
http://dx.doi.org/10.1007/s13539-012-0077-3
_version_ 1782260451388686336
author Candow, Darren G.
Chilibeck, Philip D.
Weisgarber, Krissy
Vogt, Emelie
Baxter-Jones, Adam D. G.
author_facet Candow, Darren G.
Chilibeck, Philip D.
Weisgarber, Krissy
Vogt, Emelie
Baxter-Jones, Adam D. G.
author_sort Candow, Darren G.
collection PubMed
description BACKGROUND: Postmenopausal women typically experience accelerated muscle loss which has a negative effect on strength. The maximum daily recommended dosage of ibuprofen (1,200 mg) following resistance exercise has been shown to increase muscle hypertrophy and strength in older adults. This study aimed to determine the effects of low-dose ibuprofen (400 mg) immediately following resistance exercise sessions on muscle mass and strength in postmenopausal women. METHODS: Participants were randomized to ingest ibuprofen (IBU: n = 15, 57.8 ± 5.1 years, 75.9 ± 9.0 kg, 165.9 ± 6.2 cm, BMI = 28 ± 4 kg/m(2)) or placebo (PLA: n = 13, 56.5 ± 4.4 years, 73.0 ± 10.4 kg, 163.1 ± 5.9 cm, BMI = 26 ± 9 kg/m(2)) immediately following resistance exercise (11 whole-body exercises), which was performed 3 days/week, on nonconsecutive days, for 9 weeks. Prior to and following training, measures were taken for lean tissue mass (dual-energy X-ray absorptiometry), muscle size of the elbow and knee flexors and extensors and ankle dorsiflexors and plantar flexors (ultrasound), and strength (one-repetition maximum leg press and chest press). RESULTS: Over the 9 weeks of training, there were significant changes (p < 0.05) in lean tissue mass (IBU, −1.1 ± 1.0 kg; PLA, −0.7 ± 1.4 kg), muscle size of the knee extensors (IBU, 0.3 ± 0.6 cm; PLA, 0.2 ± 0.7 cm), ankle dorsiflexors (IBU, 0.5 ± 0.8 cm; PLA, 0.1 ± 0.5 cm), and ankle plantar flexors (IBU, 0.3 ± 0.9 cm; PLA, 0.5 ± 0.9 cm), leg press strength (IBU, 20.6 ± 18.0 kg; PLA, 20.0 ± 20.0 kg), and chest press strength (IBU, 5.1 ± 9.5 kg; PLA, 8.1 ± 7.6 kg), with no differences between groups. CONCLUSION: Low-dose ibuprofen following resistance exercise has no greater effect on muscle mass or strength over exercise alone in postmenopausal women.
format Online
Article
Text
id pubmed-3581617
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-35816172013-03-01 Ingestion of low-dose ibuprofen following resistance exercise in postmenopausal women Candow, Darren G. Chilibeck, Philip D. Weisgarber, Krissy Vogt, Emelie Baxter-Jones, Adam D. G. J Cachexia Sarcopenia Muscle Original Article BACKGROUND: Postmenopausal women typically experience accelerated muscle loss which has a negative effect on strength. The maximum daily recommended dosage of ibuprofen (1,200 mg) following resistance exercise has been shown to increase muscle hypertrophy and strength in older adults. This study aimed to determine the effects of low-dose ibuprofen (400 mg) immediately following resistance exercise sessions on muscle mass and strength in postmenopausal women. METHODS: Participants were randomized to ingest ibuprofen (IBU: n = 15, 57.8 ± 5.1 years, 75.9 ± 9.0 kg, 165.9 ± 6.2 cm, BMI = 28 ± 4 kg/m(2)) or placebo (PLA: n = 13, 56.5 ± 4.4 years, 73.0 ± 10.4 kg, 163.1 ± 5.9 cm, BMI = 26 ± 9 kg/m(2)) immediately following resistance exercise (11 whole-body exercises), which was performed 3 days/week, on nonconsecutive days, for 9 weeks. Prior to and following training, measures were taken for lean tissue mass (dual-energy X-ray absorptiometry), muscle size of the elbow and knee flexors and extensors and ankle dorsiflexors and plantar flexors (ultrasound), and strength (one-repetition maximum leg press and chest press). RESULTS: Over the 9 weeks of training, there were significant changes (p < 0.05) in lean tissue mass (IBU, −1.1 ± 1.0 kg; PLA, −0.7 ± 1.4 kg), muscle size of the knee extensors (IBU, 0.3 ± 0.6 cm; PLA, 0.2 ± 0.7 cm), ankle dorsiflexors (IBU, 0.5 ± 0.8 cm; PLA, 0.1 ± 0.5 cm), and ankle plantar flexors (IBU, 0.3 ± 0.9 cm; PLA, 0.5 ± 0.9 cm), leg press strength (IBU, 20.6 ± 18.0 kg; PLA, 20.0 ± 20.0 kg), and chest press strength (IBU, 5.1 ± 9.5 kg; PLA, 8.1 ± 7.6 kg), with no differences between groups. CONCLUSION: Low-dose ibuprofen following resistance exercise has no greater effect on muscle mass or strength over exercise alone in postmenopausal women. Springer-Verlag 2012-07-10 2013-03 /pmc/articles/PMC3581617/ /pubmed/22777756 http://dx.doi.org/10.1007/s13539-012-0077-3 Text en © Springer-Verlag 2012
spellingShingle Original Article
Candow, Darren G.
Chilibeck, Philip D.
Weisgarber, Krissy
Vogt, Emelie
Baxter-Jones, Adam D. G.
Ingestion of low-dose ibuprofen following resistance exercise in postmenopausal women
title Ingestion of low-dose ibuprofen following resistance exercise in postmenopausal women
title_full Ingestion of low-dose ibuprofen following resistance exercise in postmenopausal women
title_fullStr Ingestion of low-dose ibuprofen following resistance exercise in postmenopausal women
title_full_unstemmed Ingestion of low-dose ibuprofen following resistance exercise in postmenopausal women
title_short Ingestion of low-dose ibuprofen following resistance exercise in postmenopausal women
title_sort ingestion of low-dose ibuprofen following resistance exercise in postmenopausal women
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581617/
https://www.ncbi.nlm.nih.gov/pubmed/22777756
http://dx.doi.org/10.1007/s13539-012-0077-3
work_keys_str_mv AT candowdarreng ingestionoflowdoseibuprofenfollowingresistanceexerciseinpostmenopausalwomen
AT chilibeckphilipd ingestionoflowdoseibuprofenfollowingresistanceexerciseinpostmenopausalwomen
AT weisgarberkrissy ingestionoflowdoseibuprofenfollowingresistanceexerciseinpostmenopausalwomen
AT vogtemelie ingestionoflowdoseibuprofenfollowingresistanceexerciseinpostmenopausalwomen
AT baxterjonesadamdg ingestionoflowdoseibuprofenfollowingresistanceexerciseinpostmenopausalwomen